Actively Recruiting
68Ga-MY6349 PET/CT in Solid Tumors
Led by The First Affiliated Hospital of Xiamen University · Updated on 2025-07-15
300
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of the study is to construct a noninvasive approach 68Ga-MY6349 PET/CT to detect the Trop-2 expression of tumor lesions in patients with solid tumors and to identify patients benefiting from Trop-2 PET/CT.
CONDITIONS
Official Title
68Ga-MY6349 PET/CT in Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Patients with suspected, newly diagnosed, or previously treated malignant tumors confirmed by MRI, CT, tumor markers, or pathology
- Patients scheduled for both standard-of-care imaging and 68Ga-MY6349 PET/CT scans
- Patients able to provide informed consent and assent according to ethics guidelines
You will not qualify if you...
- Patients who are pregnant
- Patients unable or unwilling to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China, 361000
Actively Recruiting
Research Team
L
Liang Zhao, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here